Graves' disease and hyperthyroidism trials in France
4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Where
- Angers, Bron, Nantes, Paris
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07596849 · EU 2025-523333-26-00 - No phaseTaking peopleProspective Evaluation of OptiThyDose
- Where
- Paris
- Age
- Up to 18 years
- People
- 150 worldwide
- Run by
- University Children's Hospital Basel
See details and how to joinNCT06864351 - No phaseTaking peopleDescribe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment
- Where
- Caen, Lyon, Marseille, Montpellier, Nîmes, Paris, Rennes, Strasbourg
- Age
- 18 years and over
- People
- 100
- Run by
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
See details and how to joinNCT07117981 - No phaseTaking peopleThyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
- Where
- Nancy
- Age
- 18 years and over
- People
- 486 worldwide
- Run by
- Andrea Goldmann
See details and how to joinNCT06963203